BioSpace News Archive

6-16 Infinitus Standardized Operation Awareness Day again highlights the importance of standardizing operations

The 6-16 Infinitus Standardized Operation Awareness Day and the 2019 Standardization Forum was held at Infinitus’ production base in Xinhui, Jiangmen, Guangdong province on June 13.

June 21, 2019
·
5 min read
Business

Abzena Expands Leadership Team With Andrew Kraus as Chief Technology Officer and Philip Payne as Chief Commercial Officer

Abzena, the leading global biologics and ADC target partner research organization, announced it has appointed Andrew Kraus as Chief Technology Officer and Philip Payne as Chief Commercial Officer.

June 21, 2019
·
2 min read
Drug Development

Achieve Life Sciences Announces Phase 2b ORCA-1 Trial Data Accepted for Oral Presentation at Society for Research on Nicotine & Tobacco Europe (SRNT-E) 19th Annual Conference

Achieve Life Sciences, Inc. announced that an abstract featuring data from the Phase 2b ORCA-1 trial has been accepted for oral presentation at the SRNT-E Annual Conference, to be held in Oslo, September 12-14, 2019.

June 21, 2019
·
4 min read
Statement - On National Indigenous Peoples Day, let’s applaud the achievements of our Indigenous health leaders

On behalf of Canada’s physicians, we’re honoured to be celebrating National Indigenous Peoples Day.

June 21, 2019
·
1 min read
Deals

Aurinia Reminds Shareholders to Vote the YELLOW Proxy Prior to June 24 Deadline

Aurinia Pharmaceuticals Inc. reminded shareholders to vote in advance of the proxy voting deadline of 10:00 AM Mountain Time on Monday, June 24, 2019.

June 21, 2019
·
8 min read
Policy

OTC Markets Group Welcomes Eve & Co Incorporated to OTCQX

OTC Markets Group Inc. announced Eve & Co Incorporated, a company that holds cultivation and processing licenses under the Cannabis Act through its wholly owned subsidiary Natural MedCo Ltd., has qualified to trade on the OTCQX® Best Market.

June 21, 2019
·
2 min read
Drug Development

Verastem Oncology Presents COPIKTRA™ (Duvelisib) Data in Peripheral T-Cell Lymphoma at the 2019 International Conference on Malignant Lymphoma

Verastem, Inc. announced an oral presentation highlighting supportive Phase 1 clinical data for duvelisib in patients with relapsed or refractory peripheral T-cell lymphoma at the 2019 International Conference on Malignant Lymphoma being held June 18-22, 2019, in Lugano, Switzerland.

June 21, 2019
·
21 min read
AMPLEXOR Life Sciences to Present and Exhibit at Upcoming DIA 2019 Global Annual Meeting

The DIA 2019 Global Annual Meeting will host more than 7,000 professionals in the pharmaceutical, biotechnology, and medical device communities as well as 400 exhibiting companies, including AMPLEXOR.

June 21, 2019
·
2 min read
Drug Development

Alnylam Announces Progress with RNAi Therapeutics Platform, Including Oral Route of Administration and CNS and Ocular Delivery

Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced new advances in its RNAi therapeutics platform, including preclinical results demonstrating oral delivery of GalNAc-conjugated small interfering RNAs – the molecules that mediate RNAi – directed to a liver target.

June 21, 2019
·
9 min read
CannTrust Holdings Announces Voting Results from 2019 Annual and Special Meeting of Shareholders

CannTrust Holdings Inc. (“CannTrust” or the “Company”, TSX:TRST, NYSE:CTST) announces the voting results on the matters submitted to shareholders at the Company’s Annual and Special Meeting of shareholders held on June 20, 2019.

June 21, 2019
·
2 min read